Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    12.60 (2.59%)
Bid:
500.00
Ask:
501.00
Spread: 1.00 (0.20%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Directorate Change

13 Dec 2016 07:00

RNS Number : 6333R
Chemring Group PLC
13 December 2016
 

FOR IMMEDIATE RELEASE 13 DECEMBER 2016

 

 

 

CHEMRING GROUP PLC

 

APPOINTMENT OF GROUP FINANCE DIRECTOR

 

Chemring Group PLC ("Chemring" or "the Group") is pleased to announce the appointment of Andrew Lewis as Group Finance Director.

 

Until 30 November 2016 Andrew was Group Finance Director of Avon Rubber p.l.c. ("Avon"), a role he held since September 2008. In partnership with the former CEO, he was instrumental in the turnaround and subsequent growth of Avon from a £10m to £300m market capitalisation company. He has a strong track record of consistent organic earnings growth and cash generation, supplemented by technology driven M&A activity. In 2015 he performed the Interim CEO role, following the retirement of the previous CEO.

 

Andrew was awarded the Finance Director of the Year Award at the Quoted Company Awards in 2016 and the Young Finance Director of the Year Award at the ICAEW Financial Director's Excellence Awards in May 2011. He also gained a wide range of international experience as a Director at PricewaterhouseCoopers in Bristol and New Zealand before joining Rotork p.l.c. as Group Financial Controller. He holds a 1st Class joint honours degree in Mathematics and Accounting from the University College of North Wales, Bangor and is a Fellow of the ICAEW.

 

Andrew will join Chemring on 9 January 2017 and will join the Board of Chemring on 19 January 2017, following publication of the Group's final results for the year ended 31 October 2016. He will take over from Andrew Davies, Deputy Group Finance Director, who was appointed Interim Finance Director following the departure of Steve Bowers on 30 September 2016.

 

Carl-Peter Forster, Chairman of Chemring, said:

 

"I am delighted to welcome Andrew to Chemring's Board. He has a proven track record of success within our sector and enhancing shareholder value.

 

Considerable work has been done in the past couple of years to strengthen the Group's balance sheet and improve its financial controls. Andrew's experience and drive will benefit the Group as we seek to progress our operational and financial performance."

 

There are no other matters requiring disclosure under Listing Rule 9.6.13.

 

-ENDS-

 

 

For further information:

 

Michael Flowers Group Chief Executive, Chemring Group PLC 01794 833901

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

John Olsen

James White

 

Notes to editors

 

· Chemring is a global business that specialises in the manufacture of high technology products and services to the aerospace, defence and security markets

· Employing approximately 2,700 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries worldwide

· Chemring is now organised under three strategic product segments: Countermeasures, Sensors & Electronics, and Energetic Systems

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, mission and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABCBDDDGBBGLD
Date   Source Headline
19th Jun 202612:00 pmRNSHolding(s) in Company
18th Jun 20267:00 amRNSBlock listing Interim Review
18th Jun 20267:00 amRNSBlock listing update
18th Jun 20267:00 amRNSHolding(s) in Company
17th Jun 20268:49 amRNSHolding(s) in Company
16th Jun 20268:58 amRNSHolding(s) in Company
15th Jun 20262:21 pmRNSHolding(s) in Company
10th Jun 202610:31 amRNSHolding(s) in Company
3rd Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20267:02 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim results
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20262:36 pmRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
21st May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20263:46 pmRNSDirector/PDMR Shareholding
19th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20267:00 amRNSAppointment of non-executive director
2nd Mar 20269:15 amRNSTotal Voting Rights
20th Feb 20262:48 pmRNSResult of AGM
20th Feb 20267:00 amRNSAGM Update
16th Feb 20267:00 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:41 pmRNSDirector/PDMR Shareholding
12th Jan 20261:35 pmRNSNotice of AGM
2nd Jan 202610:29 amRNSTotal Voting Rights
19th Dec 202511:53 amRNSHolding(s) in Company
19th Dec 202511:53 amRNSHolding(s) in Company
18th Dec 20257:00 amRNSBlock listing Interim Review
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
15th Dec 20258:42 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20253:01 pmRNSAdditional Listing - Replacement
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 202512:41 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:38 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.